indium radioisotopes

Preferred Label : indium radioisotopes;

MeSH definition : Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes.;

MeSH synonym : radioisotopes, indium;

MeSH annotation : In-106-112, 113m, 114, 116-124; for routine use as tracer, use no qualifiers; for routine use as tracer, use no qualifiers;

Is substance : O;

Details

Origin ID

D007205;

UMLS CUI

C0021224;

ATC code(s)
- indium (111in) capromab pendetide [ATC Code]
- indium (111in) pentetic acid [ATC Code]
- indium (111in) pentetreotide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 109 indium [SNOMED Notion]
- 110 indium [SNOMED Notion]
- 111 indium [SNOMED Notion]
- 117 indium [SNOMED Notion]
- In-111 [Radlex concept]
- Indium In-111 [NCIt concept]
- Product containing indium-111 (medicinal product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Indium radioisotope (substance) [SNOMED CT concept]
- indium radioisotope, nos [SNOMED Notion]
Indexing information
- (111)In-Fab-DTPA antimyosine [MeSH Supplementary Concept]
- (Lys(40)(Ahx-DTPA-111In)NH2)exendin-14 [MeSH Supplementary Concept]
- 111-indium-ethylenediaminetetracetic acid-biotin [MeSH Supplementary Concept]
- 111In-((DOTA)Ser1,Leu8,Trp22,Tyr25)SS28 [MeSH Supplementary Concept]
- 111In-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA(0)),1-Nal(3),Thr(8))octreotide [MeSH Supplementary Concept]
- 111In-CHX-A''-DTPA-Z(HER2;342) affibody [MeSH Supplementary Concept]
- 111In-DOTA-TOC [MeSH Supplementary Concept]
- 111In-DOTA-Z(HER2-342-pep2) [MeSH Supplementary Concept]
- 111In-DOTA-Z09591 [MeSH Supplementary Concept]
- 111In-DOTA-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl) [MeSH Supplementary Concept]
- 111In-DOTA-p-nitrophenylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-threonyl-cysteinyl)tyrosinamide [MeSH Supplementary Concept]
- 111In-DTPA-N-TIMP-2 [MeSH Supplementary Concept]
- 111In-DTPA-trastuzumab [MeSH Supplementary Concept]
- 111In-EC0800 [MeSH Supplementary Concept]
- 111In-benzyl-DTPA-ZHER2:342 [MeSH Supplementary Concept]
- 111In-bis-5-hydroxytryptamide-diethylenetriamine-pentaacetate [MeSH Supplementary Concept]
- 111In-diDTPA-FKYK [MeSH Supplementary Concept]
- 111In-nuclear translocation sequence-7G3 [MeSH Supplementary Concept]
- 111In-octreotate, DOTA(0)-Tyr(3)-Thr(8)- [MeSH Supplementary Concept]
- 111In-octreotide, DTPA(0)- [MeSH Supplementary Concept]
- 111In-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Phe(4-NO2)-cyclo(Cys-Tyr-Trp-Lys-Thr-Cys)-Tyr-NH2 [MeSH Supplementary Concept]
- 111indium-DOTA, Tyr(3)-octreotate [MeSH Supplementary Concept]
- 111indium-DTPA-Ac-TZ14011 [MeSH Supplementary Concept]
- ATN 10 [MeSH Supplementary Concept]
- ATN-2 [MeSH Supplementary Concept]
- Capromab Pendetide [MeSH Supplementary Concept]
- DOTALAN [MeSH Supplementary Concept]
- DTPA folate [MeSH Supplementary Concept]
- DTPA pentetreotide [MeSH Supplementary Concept]
- DTPA(1)-Lys(3),Tyr(4)bombesin [MeSH Supplementary Concept]
- DTPA-B2 [MeSH Supplementary Concept]
- DTPA-IgG complex [MeSH Supplementary Concept]
- DTPA-Pro(1),Tyr(4)bombesin [MeSH Supplementary Concept]
- DTPA-heparin [MeSH Supplementary Concept]
- DTPA-methotrexate [MeSH Supplementary Concept]
- In-DOTA-NSC-ST [MeSH Supplementary Concept]
- Indium 111In-satumomab pendetide [MeSH Supplementary Concept]
- N,N-bis(2-(bis(2-ethylhexylcarbamoylethyl)amino)ethyl)glycine [MeSH Supplementary Concept]
- N,N-bis(2-(bis(n-heptylcarbamoyl)amino)ethyl)glycine [MeSH Supplementary Concept]
- N-alpha-DTPA-tyrosyl-N-epsilon-DTPA-lysine [MeSH Supplementary Concept]
- SDZ 215-811 [MeSH Supplementary Concept]
- acetylacetone [MeSH Supplementary Concept]
- alpha,omega-(bis)DTPA-biocytin [MeSH Supplementary Concept]
- biotinyl-hydrazino-EDTA [MeSH Supplementary Concept]
- edotreotide [MeSH Supplementary Concept]
- imciromab pentetate [MeSH Supplementary Concept]
- indifor [MeSH Supplementary Concept]
- indium 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid [MeSH Supplementary Concept]
- indium 1-(4-isothiocyanatobenzyl)ethylenediaminetetraacetic acid [MeSH Supplementary Concept]
- indium 111-DOTA-lanreotide [MeSH Supplementary Concept]
- indium 111-cT84.66 monoclonal antibody [MeSH Supplementary Concept]
- indium DTPA-RC-160 [MeSH Supplementary Concept]
- indium DTPA-adriamycin [MeSH Supplementary Concept]
- indium DTPA-albumin [MeSH Supplementary Concept]
- indium DTPA-bis(stearylamide) [MeSH Supplementary Concept]
- indium DTPA-epsilon-lysine [MeSH Supplementary Concept]
- indium benzyldiethylenetriaminepentaacetic acid [MeSH Supplementary Concept]
- indium ferric colloid [MeSH Supplementary Concept]
- indium in 113m sulfur colloid [MeSH Supplementary Concept]
- indium oxine [MeSH Supplementary Concept]
- indium polylysine-EAK [MeSH Supplementary Concept]
- indium tetraphenylporphyrin [MeSH Supplementary Concept]
- indium trichloride [MeSH Supplementary Concept]
- indium tris(tropolonate) [MeSH Supplementary Concept]
- indium(111)-ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) [MeSH Supplementary Concept]
- indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [MeSH Supplementary Concept]
- indium-111-DTPA-CTT [MeSH Supplementary Concept]
- indium-111-octreotide [MeSH Supplementary Concept]
- indium-bleomycin [MeSH Supplementary Concept]
- indium-ethylenedicysteine [MeSH Supplementary Concept]
- monoclonal antibody ZCE 025 [MeSH Supplementary Concept]
- pentetreotide [MeSH Supplementary Concept]
- pyrithione [MeSH Supplementary Concept]
- substance P, Indium-111-DTPA-Arg(1)- [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- In-111 satumomab [LOINC part]
Record concept(s)
- indium radioisotopes [MeSH concept]
Related MeSH Supplementary Concept(s)
- Indium-105 [MeSH Supplementary Concept]
- Indium-110 [MeSH Supplementary Concept]
- Indium-111 [MeSH Supplementary Concept]
- Indium-113m [MeSH Supplementary Concept]
- Indium-114 [MeSH Supplementary Concept]
- Indium-114m [MeSH Supplementary Concept]
- Indium-115m [MeSH Supplementary Concept]
- Indium-123 [MeSH Supplementary Concept]
- Indium-131 [MeSH Supplementary Concept]
See also
- indium [MeSH Descriptor]
Semantic type(s)
- Element, Ion, or Isotope [UMLS semantic type]
UMLS correspondences (same concept)
- Indium radioisotope (substance) [SNOMED CT concept]
- Product containing indium radioisotope (product) [SNOMED CT concept]
- indium radioisotope, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- 114 indium [SNOMED Notion]
- Indium (111In) [SMS substance]
- Indium-109 (substance) [SNOMED CT concept]
- Indium-110 (substance) [SNOMED CT concept]
- Indium-111 (substance) [SNOMED CT concept]
- Indium-114 (substance) [SNOMED CT concept]
- Indium-117 (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients